Beyond Beta-Amyloid: Alzheimer’s and Gene Therapy
<p>You have an idea that could benefit hundreds of millions of people, but pursuing it might kill your career.</p>
<p>So, you stick with the accepted way of doing things, even though, after many decades, it’s not yielding any promising leads. It’s a flawed idea rooted in a shallow understanding of a complicated problem.</p>
<p>This fixedness is costing people their savings and their lives.</p>
<p>This was, and is, the state of affairs in Alzheimer’s research thanks to the beta-amyloid hypothesis. Dr. Rachel Neve, a neurobiologist at Mass General, calls the amyloid hypothesis “one of the most tragic stories [in] disease research.”</p>
<p><a href="https://bioviva-science.medium.com/beyond-beta-amyloid-alzheimers-and-gene-therapy-2ecfe640b678"><strong>Click Here</strong></a></p>